Cita APA (7a ed.)

Alves, C. L., Ehmsen, S., Terp, M. G., Portman, N., Tuttolomondo, M., Gammelgaard, O. L., . . . Ditzel, H. J. (2021). Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Alves, Carla L., et al. Publisher Correction: Co-targeting CDK4/6 and AKT with Endocrine Therapy Prevents Progression in CDK4/6 Inhibitor and Endocrine Therapy-resistant Breast Cancer. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Alves, Carla L., et al. Publisher Correction: Co-targeting CDK4/6 and AKT with Endocrine Therapy Prevents Progression in CDK4/6 Inhibitor and Endocrine Therapy-resistant Breast Cancer. Nature Portfolio, 2021.